These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11807530)

  • 21. Anthrax: from antiquity to answers.
    Artenstein AW
    J Infect Dis; 2007 Feb; 195(4):471-3. PubMed ID: 17230405
    [No Abstract]   [Full Text] [Related]  

  • 22. Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli.
    Mock M; Labruyère E; Glaser P; Danchin A; Ullmann A
    Gene; 1988 Apr; 64(2):277-84. PubMed ID: 2841199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A; Midha S; Bhatnagar R
    Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthrax X-rayed: new opportunities for biodefence.
    Stubbs MT
    Trends Pharmacol Sci; 2002 Dec; 23(12):539-41. PubMed ID: 12457764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dominant-negative therapy for anthrax.
    Leppla SH
    Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497
    [No Abstract]   [Full Text] [Related]  

  • 26. The roles of anthrax toxin in pathogenesis.
    Moayeri M; Leppla SH
    Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a Bacillus anthracis isolate causing a rare case of fatal anthrax in a 2-year-old boy from Hong Kong.
    Cheung DT; Kam KM; Hau KL; Au TK; Marston CK; Gee JE; Popovic T; Van Ert MN; Kenefic L; Keim P; Hoffmaster AR
    J Clin Microbiol; 2005 Apr; 43(4):1992-4. PubMed ID: 15815041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of biologically active Bacillus anthracis edema factor in Escherichia coli.
    Cooksey BA; Sampey GC; Pierre JL; Zhang X; Karwoski JD; Choi GH; Laird MW
    Biotechnol Prog; 2004; 20(6):1651-9. PubMed ID: 15575695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
    Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
    J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemistry. Nota bene: know thine enemy.
    Smith O
    Science; 2001 Nov; 294(5545):1298. PubMed ID: 11701920
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK; Boehm R; Beyer W
    Vaccine; 2006 May; 24(21):4569-71. PubMed ID: 16157424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B.
    Gutting BW; Gaske KS; Schilling AS; Slaterbeck AF; Sobota L; Mackie RS; Buhr TL
    Toxicol In Vitro; 2005 Mar; 19(2):221-9. PubMed ID: 15649636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis.
    Little SF
    Biochem Biophys Res Commun; 2004 Apr; 317(1):294-300. PubMed ID: 15047182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiology. Translocation of anthrax toxin: lord of the rings.
    von Heijne G
    Science; 2005 Jul; 309(5735):709-10. PubMed ID: 16051774
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening inhibitors of anthrax lethal factor.
    Tonello F; Seveso M; Marin O; Mock M; Montecucco C
    Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Some important biological active genes of bacillus anthracis and its regulation ].
    Li W; Yu DZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):445-8. PubMed ID: 15231178
    [No Abstract]   [Full Text] [Related]  

  • 39. Anthrax toxins.
    Duesbery NS; Vande Woude GF
    Cell Mol Life Sci; 1999 Sep; 55(12):1599-609. PubMed ID: 10526577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.
    Banks DJ; Barnajian M; Maldonado-Arocho FJ; Sanchez AM; Bradley KA
    Cell Microbiol; 2005 Aug; 7(8):1173-85. PubMed ID: 16008584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.